Lamotrigine brand change

Lamotrigine is used to treat epilepsy and some mental health conditions, such as bipolar disorder.

Applications to fund Arrow-Lamotrigine and Lamictal

  • Total number of patients: 2,526
  • Applications under assessment: 21
  • Approved: 2,418
  • Declined: 78
  • Withdrawn: 9

The number of declined applications has increased because dispensing data indicated that these applications were for people who:

  • were not previously on another brand of lamotrigine and for who Logem is an appropriate treatment option or
  • had not been prescribed lamotrigine for mental health or epilepsy indications. 

> Read the criteria for funding alternative brands of lamotrigine

As at: 14 July 2020